Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rapport Therapeutics, Inc.

31.47
+17.11119.15%
Pre-market: 30.70-0.7700-2.45%07:08 EDT
Volume:13.88M
Turnover:482.52M
Market Cap:1.15B
PE:-12.56
High:42.27
Open:38.42
Low:27.05
Close:14.36
52wk High:42.27
52wk Low:6.43
Shares:36.50M
Float Shares:14.96M
Volume Ratio:41.34
T/O Rate:92.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5062
EPS(LYR):-3.7760
ROE:-29.42%
ROA:-20.14%
PB:4.36
PE(LYR):-8.33

Loading ...

Sep 08, 2025

Major Issues Report

Form 8-K - Current report
Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2025

Major Issues Report

Form 8-K - Current report
Jul 08, 2025

Correspondence

Form CORRESP - Correspondence
Jul 08, 2025

Correspondence

Form CORRESP - Correspondence
Jun 18, 2025

Major Issues Report

Form 8-K - Current report
Jun 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 02, 2025

Major Issues Report

Form 8-K - Current report
May 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2025

Major Issues Report

Form 8-K - Current report
Mar 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 11, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 11, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2025

Major Issues Report

Form 8-K - Current report
Mar 03, 2025

Major Issues Report

Form 8-K - Current report
Jan 10, 2025

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]